Jefferies Financial Group cut shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) from a buy rating to a hold rating in a research note published on Monday, Marketbeat reports. They currently have $33.00 price target on the stock, up from their prior price target of $24.00. The analysts noted that the move was a valuation […]
BridgeBio Pharma, Inc (NASDAQ:BBIO) Sees Significant Growth in Short Interest themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ronald Daniels and some trustees at the Johns Hopkins University have outside board seats that prompted some critics to raise conflict-of-interest concerns.
Burjeel Holdings to Launch Rare Disease Research & Development Project NADER in Partnership with US-based BridgeBio Pharma itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.